Group One Trading, L.P. Inovio Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.35 - $0.53 $4,291 - $6,498	12,261 Added 38.2%	44,360 $22,000
Q3 2023 Nov 09, 2023	SELL	$0.38 - $0.58 $2,834 - $4,326	-7,459 Reduced 18.86%	32,099 $12,000
Q2 2023 Aug 09, 2023	SELL	$0.39 - $0.94 $1,911 - $4,606	-4,900 Reduced 11.02%	39,558 $17,000
Q1 2023 May 12, 2023	BUY	$0.79 - $1.91 $35,121 - $84,914	44,458 New	44,458 $36,000
Q3 2022 Nov 09, 2022	BUY	$1.66 - $2.79 $1,978 - $3,325	1,192 New	1,192 $2,000
Q2 2022 Aug 11, 2022	SELL	$1.44 - $3.98 $270,681 - $748,132	-187,973 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.97 - $5.2 $543,756 - $952,031	183,083 Added 3744.03%	187,973 $675,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $24,401 - $36,479	4,890 New	4,890 $24,000
Q4 2019 Feb 10, 2020	SELL	$1.97 - $3.72 $11,431 - $21,587	-5,803 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.05 - $3.02 $31,164 - $45,910	-15,202 Reduced 72.37%	5,803 $12,000
Q2 2019 Aug 09, 2019	SELL	$2.29 - $4.1 $14,427 - $25,829	-6,300 Reduced 23.07%	21,005 $62,000
Q1 2019 May 13, 2019	BUY	$3.34 - $5.1 $63,396 - $96,803	18,981 Added 228.03%	27,305 $102,000
Q4 2018 Feb 06, 2019	BUY	$3.89 - $6.11 $11,245 - $17,664	2,891 Added 53.21%	8,324 $33,000
Q3 2018 Nov 08, 2018	SELL	$3.92 - $5.58 $26,213 - $37,313	-6,687 Reduced 55.17%	5,433 $30,000
Q2 2018 Aug 14, 2018	SELL	$3.88 - $5.16 $142,640 - $189,697	-36,763 Reduced 75.21%	12,120 $48,000
Q1 2018 May 11, 2018	BUY	$4.05 - $5.69 $186,781 - $262,417	46,119 Added 1668.56%	48,883 $230,000
Q4 2017 Feb 09, 2018	BUY	$4.13 - $6.68 $11,415 - $18,463	2,764 New	2,764 $11,000
Q3 2017 Nov 15, 2017	SELL	$5.36 - $6.37 $121,066 - $143,879	-22,587 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	22,587	22,587 $177,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $546M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account